← Leaderboards
Natalie L Rasgon
University Of California Los Angeles
$9,504,066
Attributed
$9,504,066
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,504,066 · 18
By mechanism
R01$7,922,658 · 3
K12$500,000 · 1
R21$434,500 · 1
R29$316,251 · 1
M01$305,657 · 11
R13$25,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Robert M Bilder$17,375,234
- Alan H. Decherney$2,882,066
- Kathleen A. Kelly$7,380,773
- Michael A Strober$5,065,183
- Madhuri Wadehra$1,352,273
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMetabolicCognitiveEvaluationMood DisordersWomanPerformanceDesignInsulin ResistanceGrantRisk FactorsPostmenopauseEndocrineEstrogensObesityGuidelinesFollow-UpFamily History OfS Disease RiskImpaired CognitionElderlyRecording Of Previous EventsCognitionPharmaceutical Preparations
Grant awards (36)
Insulin Resistance and Accelerated Cognitive Aging$660,970
R01 · FY2020 · AG · contact PI
Insulin Resistance and Accelerated Cognitive Aging$246,167
R01 · FY2020 · AG · contact PI
Insulin Resistance and Accelerated Cognitive Aging$655,403
R01 · FY2019 · AG · contact PI
Insulin Resistance and Accelerated Cognitive Aging$571,521
R01 · FY2018 · AG · contact PI
Insulin Resistance and Accelerated Cognitive Aging$766,585
R01 · FY2017 · AG · contact PI
Insulin Resistance and Accelerated Cognitive Aging$770,740
R01 · FY2016 · AG · contact PI
Pioglitazone for Treatment of Unremitted Depression in Insulin Resistant Patients$197,500
R21 · FY2012 · MH · contact PI
Pioglitazone for Treatment of Unremitted Depression in Insulin Resistant Patients$237,000
R21 · FY2011 · MH · contact PI
Estrogen Use in Protection from Cognitive Decline$75,000
R01 · FY2010 · AG · contact PI
Window of Opportunity of Estrogen Therapy for Neuroprotection$25,000
R13 · FY2009 · AG · contact PI
Endocrine Function and Mood in Bipolar Disorder$341,346
R01 · FY2008 · MH · contact PI
Estrogen Use in Protection from Cognitive Decline$150,000
R01 · FY2008 · AG · contact PI
CLINICAL TRIAL: ESTROGEN USE IN PROTECTION FROM COGNITIVE DECLINE$12,060
M01 · FY2008 · RR · contact PI
REPRODUCTIVE ENDOCRINE FUNCTION AND MOOD IN WOMEN WITH BIPOLAR DISORDER$5,802
M01 · FY2008 · RR · contact PI
INSULIN RESISTANCE IN MOOD DISORDERS$4,096
M01 · FY2008 · RR · contact PI
ADJUNCTIVE ZIPRASIDONE IN OVERWEIGHT AND OBESE PATIENTS WITH BIPOLAR DISORDER$4,096
M01 · FY2008 · RR · contact PI
Estrogen Use in Protection from Cognitive Decline$448,914
R01 · FY2007 · AG · contact PI
Endocrine Function and Mood in Bipolar Disorder$328,617
R01 · FY2007 · MH · contact PI
ESTROGEN USE IN PROTECTION FROM COGNITIVE DECLINE$71,388
M01 · FY2007 · RR · contact PI
REPRODUCTIVE ENDOCRINE FUNCTION AND MOOD IN WOMEN WITH BIPOLAR DISORDER$63,780
M01 · FY2007 · RR · contact PI
INSULIN RESISTANCE IN MOOD DISORDERS$19,894
M01 · FY2007 · RR · contact PI
Estrogen Use in Protection from Cognitive Decline$449,326
R01 · FY2006 · AG · contact PI
Endocrine Function and Mood in Bipolar Disorder$338,814
R01 · FY2006 · MH · contact PI
REPRODUCTIVE ENDOCRINE FUNCTION AND MOOD IN WOMEN WITH BIPOLAR DISORDER$76,947
M01 · FY2006 · RR · contact PI
ESTROGEN USE IN PROTECTION FROM COGNITIVE DECLINE$42,699
M01 · FY2006 · RR · contact PI
INSULIN RESISTANCE IN MOOD DISORDERS$3,559
M01 · FY2006 · RR · contact PI
Estrogen Use in Protection from Cognitive Decline$525,006
R01 · FY2005 · AG
Mentoring &Interdisciplinary Research in Women's Health$500,000
K12 · FY2005 · HD
Endocrine Function and Mood in Bipolar Disorder$347,346
R01 · FY2005 · MH
ESTROGEN USE IN PROTECTION FROM COGNITIVE DECLINE$1,336
M01 · FY2005 · RR
Estrogen Use in Protection from Cognitive Decline$447,214
R01 · FY2004 · AG
Endocrine Function and Mood in Bipolar Disorder$347,715
R01 · FY2004 · MH
Estrogen Use in Protection from Cognitive Decline$451,974
R01 · FY2003 · AG
ERT, DEPRESSION AND COGNITION IN POSTMENOPAUSAL WOMEN$105,417
R29 · FY2002 · MH
ERT, DEPRESSION AND COGNITION IN POSTMENOPAUSAL WOMEN$105,417
R29 · FY2001 · MH
ERT, DEPRESSION AND COGNITION IN POSTMENOPAUSAL WOMEN$105,417
R29 · FY2000 · MH